Sylvie Vincent
6PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 24, 2025
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity.Xiuning Le, Jacqulyne P Robichaux, Monique Nilsson
|Jan 04, 2022
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor.José Á García-Sáenz, Noelia Martínez-Jáñez, Ricardo Cubedo
|Aug 12, 2021
Targeting <i>HER2</i> Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib.Han Han, Shuai Li, Ting Chen
|Apr 06, 2021
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.Bora Lim, David A Potter, Mohamad A Salkeni
|Feb 26, 2021
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations from a Phase I/II Trial.Gregory J Riely, Joel W Neal, D Ross Camidge
|Feb 26, 2021
Mobocertinib (TAK-788): A Targeted Inhibitor of <i>EGFR</i> Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer.Francois Gonzalvez, Sylvie Vincent, Theresa E Baker
Pageof 1
Frequent Collaborators
2 joint publications
Victor M Rivera
2 joint publications
Kevin J Galinsky
1 joint publications
Matthew T Greenfield
1 joint publications
Joel W Neal
1 joint publications
Anne S Tsao
1 joint publications
Lyudmila Bazhenova
1 joint publications
Ryan D Gentzler
1 joint publications
Danny Nguyen
1 joint publications
Shu Jin
1 joint publications
Bora Lim
